These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29956791)

  • 41. The association between clinical prognostic factors and epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) efficacy in advanced non-small-cell lung cancer patients: a retrospective assessment of 94 cases with EGFR mutations.
    Lin JH; Lin D; Xu L; Wang Q; Hu HH; Xu HP; He ZY
    Oncotarget; 2017 Jan; 8(2):3412-3421. PubMed ID: 27926500
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Expression of the enhancer of zeste homolog 2 in biopsy specimen predicts chemoresistance and survival in advanced non-small cell lung cancer receiving first-line platinum-based chemotherapy.
    Xu C; Hao K; Hu H; Sheng Z; Yan J; Wang Q; Yu L
    Lung Cancer; 2014 Nov; 86(2):268-73. PubMed ID: 25262426
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of miR‑124a as a novel diagnostic and prognostic biomarker in non‑small cell lung cancer for chemotherapy.
    Luo P; Yang Q; Cong LL; Wang XF; Li YS; Zhong XM; Xie RT; Jia CY; Yang HQ; Li WP; Cong XL; Xia Q; Fu D; Zeng QH; Ma YS
    Mol Med Rep; 2017 Jul; 16(1):238-246. PubMed ID: 28534972
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Upregulated expression of ILF2 in non-small cell lung cancer is associated with tumor cell proliferation and poor prognosis.
    Ni T; Mao G; Xue Q; Liu Y; Chen B; Cui X; Lv L; Jia L; Wang Y; Ji L
    J Mol Histol; 2015 Oct; 46(4-5):325-35. PubMed ID: 26059795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Increased Expression of Long Non-Coding RNA BCAR4 Is Predictive of Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
    Gong J; Zhang H; He L; Wang L; Wang J
    Tohoku J Exp Med; 2017 Jan; 241(1):29-34. PubMed ID: 28077810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diagnostic investigation of BIRC6 and SIRT1 protein expression level as potential prognostic biomarkers in patients with non-small cell lung cancer.
    Gharabaghi MA
    Clin Respir J; 2018 Feb; 12(2):633-638. PubMed ID: 27768839
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of LGR5 and ALDH1A1 in non-small cell lung cancer: Cancer progression and prognosis.
    Gao F; Zhou B; Xu JC; Gao X; Li SX; Zhu GC; Zhang XG; Yang C
    Biochem Biophys Res Commun; 2015 Jun; 462(2):91-8. PubMed ID: 25881507
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma.
    Fujita Y; Fujikane T; Fujiuchi S; Nishigaki Y; Yamazaki Y; Nagase A; Shimizu T; Ohsaki Y; Kikuchi K
    Cancer; 2003 Sep; 98(5):1008-13. PubMed ID: 12942569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Downregulation of DLL4 predicts poor survival in non‑small cell lung cancer patients due to promotion of lymph node metastasis.
    Liu H; Peng J; Zhao M; Ma P; Zhong J; Li S; Lu Z
    Oncol Rep; 2018 Nov; 40(5):2988-2996. PubMed ID: 30226615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Over-expression of CircRNA_100876 in non-small cell lung cancer and its prognostic value.
    Yao JT; Zhao SH; Liu QP; Lv MQ; Zhou DX; Liao ZJ; Nan KJ
    Pathol Res Pract; 2017 May; 213(5):453-456. PubMed ID: 28343871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nemo-like kinase (NLK) inhibits the progression of NSCLC via negatively modulating WNT signaling pathway.
    Lv L; Wan C; Chen B; Li M; Liu Y; Ni T; Yang Y; Liu Y; Cong X; Mao G; Xue Q
    J Cell Biochem; 2014 Jan; 115(1):81-92. PubMed ID: 23904219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
    Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
    Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dichotomous ALK-IHC Is a Better Predictor for ALK Inhibition Outcome than Traditional ALK-FISH in Advanced Non-Small Cell Lung Cancer.
    van der Wekken AJ; Pelgrim R; 't Hart N; Werner N; Mastik MF; Hendriks L; van der Heijden EHFM; Looijen-Salamon M; de Langen AJ; Staal-van den Brekel J; Riemersma S; van den Borne BE; Speel EJM; Dingemans AC; Hiltermann TJN; van den Berg A; Timens W; Schuuring E; Groen HJM
    Clin Cancer Res; 2017 Aug; 23(15):4251-4258. PubMed ID: 28183714
    [No Abstract]   [Full Text] [Related]  

  • 56. Overexpression of P21-activated kinase 4 is associated with poor prognosis in non-small cell lung cancer and promotes migration and invasion.
    Cai S; Ye Z; Wang X; Pan Y; Weng Y; Lao S; Wei H; Li L
    J Exp Clin Cancer Res; 2015 May; 34(1):48. PubMed ID: 25975262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
    Xie C; Han Y; Liu Y; Han L; Liu J
    Int J Clin Exp Pathol; 2014; 7(10):6534-42. PubMed ID: 25400731
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum microRNA-365 in combination with its target gene TTF-1 as a non-invasive prognostic marker for non-small cell lung cancer.
    Liu Y; Zhang G; Li H; Han L; Fu A; Zhang N; Zheng Y
    Biomed Pharmacother; 2015 Oct; 75():185-90. PubMed ID: 26337230
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer.
    Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X
    Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.